Tumor-Targeted Salmonella: Strain Development and Expression of the HSV-tK Effector Gene

Area of Science:

• Oncology
• Microbiology
• Gene Therapy

Background:

• Cancer gene therapy faces limitations due to poor delivery vector expression in tumors.
• Physical barriers hinder therapeutic agent delivery to solid tumors, necessitating alternative methods.
• Anaerobic Clostridium spores target hypoxic tumors but are inaccessible to smaller metastases.

Purpose of the Study:

• To develop a novel tumor-targeting delivery system for gene therapy using facultative anaerobic bacteria.
• To engineer attenuated Salmonella to preferentially target, amplify within, and suppress primary and metastatic tumors.
• To present the methodology for creating effector gene-delivery capable, tumor-targeting facultative anaerobes.

Main Methods:

• Utilized motile, facultatively anaerobic Salmonella engineered with poly-auxotrophic mutations for attenuation.
• Implemented stepwise addition of point-mutations and frame-shift mutations for strain development.
• Selected and screened strains in vitro and in vivo for desired tumor-targeting and replication properties.

Main Results:

• Attenuated Salmonella demonstrated preferential amplification within tumors following systemic administration.
• Engineered Salmonella effectively suppressed both primary and metastatic tumors.
• The developed vectors expressed effector genes, such as herpes simplex virus thymidine kinase (HSV-TK).

Conclusions:

• Attenuated Salmonella represent a viable alternative to traditional delivery vectors like Clostridia, liposomes, and viruses.
• This approach overcomes limitations of physical barriers and accessibility to metastases.
• The methodology facilitates the development of robust, tumor-targeting bacterial vectors for cancer gene therapy.